aod9604 dosing frequency subcutaneous injection AOD 9604: Peptide Claims vs Clinical Reality AOD 9604 is marketed as a fat-metabolism peptide derived from a growth hormone fragment, often positioned as “HGH-like” without HGH's side effects. The clinical question AOD 9604: The Ultimate Guide
Description
Tesamorelin: Another growth hormone-releasing hormone analog studied specifically for visceral fat reduction
Wipe the injection site (belly, thigh, or upper arm) with an alcohol swab
Results depend heavily on baseline body composition, dietary adherence, exercise programming, sleep quality, stress management, genetic factors, and protocol compliance
Six Phase I/II clinical trials enrolling approximately 900 participants confirmed an excellent safety profile with no serious adverse events attributed to the compound
